A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A new case study reveals medical marijuana may provide rapid relief for sufferers of chronic itch. Researchers say THC attaches itself to brain receptors that influence the nervous system. This reduces inflammation and nervous system activity, leading to a reduction in itch sensation.
While cannabis users reported more psychotic experiences than non-users generally, the effect was more pronounced in those with a genetic risk factor for schizophrenia.
Smoking marijuana affects several key visual functions, including 3D vision and contrast sensitivity. However, 90% of cannabis users believe the drug has either no, or minimal, effect on their visual abilities.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.
Frequent cannabis use was associated with a two point decline in IQ. The decline was primarily related to verbal IQ.
People who use cannabis as a form of pain management report sleeplessness, nausea, and changes in mood or behavior when they go a significant time without using the drug.
Female rats exposed to vaporized cannabis for 30 days developed a blunted response to stress. The effect was not seen in male rats. Findings shed light on how chronic cannabis use affects males and females differently.
People with OCD reported a reduction in the symptoms within four hours of smoking cannabis, a new study reports.
Children whose mothers' used cannabis while pregnant are more likely to have an elevated risk of psychopathology during middle-school. Researchers found those exposed to cannabis in utero were more likely to experience depression, anxiety, attention problems, social-behavioral problems, and sleep disturbances. Additionally, the children showed signs of lower cognitive performance, lower indices of global brain structure, and were more likely to have a lower birth weight.
Unlike long-term opioid use, frequent cannabis use does not increase sensitivity to pain.
